Stock Forecast Chart
Stock Price Prediction Summary
Forecast Score Based on 2 Weeks
Based on our forecast, the price of CYCN will rise by +7.25% over the next 2 Weeks and hit $1.59 by Monday, March 30, 2026. In that time frame, CYCN's share price is expected to range between $1.51 and $1.68.
BearishAverageBullish| Date | Predicted Lower | Predicted | Predicted Upper |
|---|---|---|---|
| Mar 30, 2026 | 1.51 | 1.59 | 1.68 |
| Mar 27, 2026 | 1.47 | 1.56 | 1.64 |
| Mar 26, 2026 | 1.43 | 1.51 | 1.59 |
| Mar 25, 2026 | 1.47 | 1.55 | 1.63 |
| Mar 24, 2026 | 1.45 | 1.53 | 1.61 |
| Mar 23, 2026 | 1.46 | 1.54 | 1.62 |
| Mar 20, 2026 | 1.42 | 1.50 | 1.59 |
| Mar 19, 2026 | 1.38 | 1.46 | 1.54 |
| Mar 18, 2026 | 1.42 | 1.50 | 1.57 |
| Mar 17, 2026 | 1.40 | 1.48 | 1.56 |
CYCN shares rose +2.36% in Tuesday, March 17, 2026's trading session, rising from a previous close of $1.49 to move at $1.52. The stock demonstrated notable intraday movement (see CYCN's key stats for a full breakdown), fluctuating between $1.48 and $1.54, a +4.05% trading range. While recent weeks have seen some volatility, CYCN has managed to secure a +12.60% gain over the past 2 weeks. The upward price movement was accompanied by increased trading volume, with approximately 44.22K shares changing hands, 26.06K more than the previous session. This amounted to $67.21K in total market activity.
Will CYCN Continue Its Upward Trend?
According to analyst ratings and projections for CYCN, Cyclerion Therapeutics, Inc. shares are anticipated to increase by +9.40%, potentially reaching $1.68 per share by March 30, 2026. Short-term technical indicators currently suggest a neutral sentiment for CYCN. For deeper insights, view our sentiment analysis on AAPL covering social and institutional perspectives. However, the stock has recorded 14 positive trading days within the past 30 sessions. Based on the CYCN stock forecast, now is a good time to buy CYCN stock because its current trading price is -4.56% below our predicted value, hinting at a possible overvaluation. For deeper insights, view our sentiment analysis on CYCN covering social and institutional perspectives.
CYCN Technical Momentum: Overbought, Oversold, or Neutral?
An analysis of Relative Strength Index (RSI) indicators provides insight into CYCN's momentum. Short-term RSIs (9, 14, and 20-day figures ranging from 57.92% to 71.25%) suggest the stock is showing bullish momentum with some volatility. The 50-day RSI, at 49.03%, suggests a neutral medium-term outlook. Additionally, the 100-day RSI, at 47.68%, maintains a neutral outlook for the long term. Insights into CYCN's shareholder base show how institutional investors are positioning themselves during these momentum shifts
Cyclerion Therapeutics Short-Term Forecasts
CYCN Forecast For Next 5 Days
Our algorithm anticipates Cyclerion Therapeutics (CYCN) stock could hit $1.45 by Mar 24, 2026. This represents a -4.35% fall from today's price, following a -21.05% change over the past five days.
CYCN Forecast For Next 30 Days
Based on analysis of market trends, the outlook for Cyclerion Therapeutics, Inc. (CYCN) stock over the next 30 days is largely negative. Price forecasts suggest an average target of $1.41, which would mean a -7.24% decrease from the current price of $1.52. Projections for this period range from a high of $1.81 to a low of $1.12.
CYCN Forecast For Next 90 Days
Our proprietary market analysis suggests predictions for Cyclerion Therapeutics's price over the next three months point to a rise. CYCN stock is expected to peak at $3.27 on Mar 17, 2026 before potentially dipping to $1.55 on Jun 12, 2026. On average, CYCN is likely to trade around $2.37 in the coming 90 days.
Cyclerion Therapeutics Stock Forecast 2025
Based on our predictive models, Cyclerion Therapeutics (CYCN) is expected to trade between $0.00 and $3.27 throughout 2026. This would result in an average price of $1.56, potentially offering investors a +2.62% return from current levels.
Cyclerion Therapeutics, Inc. Monthly Forecast 2026–2027
March 2026
According to our latest forecast models, Cyclerion Therapeutics, Inc. (CYCN) is positioned to show a strong performance in March 2026. The price is predicted to move between $2.76 and $3.27, settling at an average of $3.04. This could translate to a +99.99% gain.
April 2026
Based on current market signals, Cyclerion Therapeutics, Inc. is projected to trend april 2026. We forecast a trading range from $2.04 to $2.99, with a likely average price of $2.43. Investors could expect a potential return of +59.86%.
May 2026
Our predictive algorithms indicate Cyclerion Therapeutics, Inc. stock may see a shift in May 2026. The expected range spans $1.79–$2.82, with an average target of $2.25. This represents a positive outlook and a possible gain of +48.02%.
June 2026
Analyzing established trends, Cyclerion Therapeutics, Inc. looks set to move in June 2026. Projections place the stock between $1.48 and $2.29, averaging around $1.86. This suggests a +22.36% gain from current levels.
July 2026
Market indicators suggest Cyclerion Therapeutics, Inc. could experience notable changes during July 2026. Prices could fluctuate within $1.14 to $1.93, with a midpoint forecast of $1.62. The stock might deliver a +6.57% gain.
August 2026
Forecasting for August 2026, models estimate that Cyclerion Therapeutics, Inc. may undergo key fluctuations. If trends hold, the stock might trade between $0.83 and $1.65, averaging $1.38. This signals a cautious trajectory with potential returns around -9.22%.
September 2026
According to our latest forecast models, Cyclerion Therapeutics, Inc. (CYCN) is positioned to show a strong performance in September 2026. The price is predicted to move between $0.53 and $1.38, settling at an average of $1.25. This could translate to a -17.77% loss.
October 2026
Based on current market signals, Cyclerion Therapeutics, Inc. is projected to trend october 2026. We forecast a trading range from $0.12 to $1.19, with a likely average price of $1.03. Investors could expect a potential return of -32.24%.
November 2026
Our predictive algorithms indicate Cyclerion Therapeutics, Inc. stock may see a shift in November 2026. The expected range spans $0.00–$0.82, with an average target of $0.73. This represents a cautious outlook and a possible loss of -51.98%.
December 2026
Analyzing established trends, Cyclerion Therapeutics, Inc. looks set to move in December 2026. Projections place the stock between $0.00 and $0.57, averaging around $0.77. This suggests a -49.35% loss from current levels.
January 2027
Market indicators suggest Cyclerion Therapeutics, Inc. could experience notable changes during January 2027. Prices could fluctuate within $0.00 to $0.24, with a midpoint forecast of $0.71. The stock might deliver a -53.29% loss.
February 2027
Forecasting for February 2027, models estimate that Cyclerion Therapeutics, Inc. may undergo key fluctuations. If trends hold, the stock might trade between $0.00 and $0.00, averaging $0.69. This signals a cautious trajectory with potential returns around -54.61%.
March 2027
According to our latest forecast models, Cyclerion Therapeutics, Inc. (CYCN) is positioned to show a strong performance in March 2027. The price is predicted to move between $0.00 and $0.00, settling at an average of $0.55. This could translate to a -63.82% loss.
CYCN's history of dividends and stock splits also plays a role in long-term investor confidence.